FMED ETF: Fidelity Disruptive Medicine ETF - Price, Holdings & Analysis
Fidelity Disruptive Medicine ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About Fidelity Disruptive Medicine ETF
What is the current price of FMED?
The latest FMED price is $24.67. The 52-week range is $20.69–$29.07. FMED has returned 6.6% over the past 52 weeks.
What is the expense ratio for FMED?
FMED's annual expense ratio is 0.50%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.
Does FMED pay dividends?
Fidelity Disruptive Medicine ETF does not currently pay dividends. Check the ETF Screener for dividend-focused alternatives in the Equity category.
What are the top holdings of FMED?
FMED's largest holdings are Danaher Corporation (4.5%), UCB SA (4.4%), argenx NV ADR (4.2%) (combined weight: 13.1%). The fund holds 72 total positions. View the complete portfolio breakdown in the Holdings section.
How does FMED compare to similar ETFs?
Compare FMED (0.50% expense ratio, $58M AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.